SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-054744
Filing Date
2023-11-27
Accepted
2023-11-27 18:24:19
Documents
1
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3793
  Complete submission text file 0001140361-23-054744.txt   5401
Mailing Address INSPIRE PHARMACEUTICALS, INC., 4222 EMPEROR BLVD., STE. 470 DURHAM NC 27703-8466
Business Address
SCHACHLE JOSEPH K (Reporting) CIK: 0001145914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 231441495

Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations